A new report on Crestor is raising safety concerns AGAIN

July 2005

A new report on Crestor is raising safety concerns AGAIN.

This analysis suggests a trend towards more cases of severe myopathy and a higher rate of proteinuria with Crestor.

Health Canada looked at this data previously and decided to leave Crestor on the market...with conservative dosing.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

pharmacogenomics to personalize drug therapy based on a person's genes
Cholesterol A new report on Crestor is raising safety concerns AGAIN
Kidney Disease best way to measure kidney function
Scientists are now taking omega-3 fatty acids more seriously
Dermatology more emphasis on using biologic agents for moderate to severe psoriasis
Dermatology recent headlines that suggest sunscreens cause cancer
Supplements How much oral vitamin B12 is needed to treat B12 deficiency
Diabetes how to PREVENT type 2 diabetes
Diabetes Accidental changes in glucometer settings can cause some patients to misinterpret their blood glucose readings
Infectious Diseases HIGHER doses of trimethoprim/ sulfamethoxazole (TMP/SMX) for certain skin infections
Infectious Diseases a new IV antibiotic called Tygacil
Infectious Diseases Zostavax, a new vaccine for shingles
Do patients at risk for anaphylaxis have to avoid beta-blockers
SSRIs seem to increase the risk of GI bleeding
adverse drug reaction reporting more accessible to the PUBLIC